Milton Hershey School Trust Sells 30,000 Hershey Shares for $5.2 Million. Here's What Investors Should Know.
2026-07-18 17:01
•Josh Kohn-Lindquist •The Motley Fool
•••••••• • Axe Capital view
Milton Hershey Trust's Share Sale: No Cause for Alarm
The recent sale of Hershey shares by its founding trust is routine and doesn't undermine the stock's credentials.
The Milton Hershey School Trust's recent disposal of 30,000 Hershey shares worth $5.2 million isn’t a red flag. The trust still holds a dominant stake, signalling confidence in the long-term story. Hershey, a classic consumer defensive name, faces some pressure from rising cocoa prices and newer health trends like GLP-1 medicines that could dent sales of sugary products. But it’s worth noting the business recently posted 11% sales growth and maintains a healthy 3.4% dividend yield. At around 20 times forward earnings, the valuation is reasonable for a steady cash generator. South African investors can view this in contrast to local consumer stocks, where inflation hits are often more acute. While the rand has held relatively steady around 18.50 to the dollar, these global cost pressures matter globally. If Hershey struggles to innovate around health trends or raw material costs escalate faster than anticipated, the share could underperform. But for now, the insider selling feels like a non-event; the fundamentals are holding up. this is just my opinion and not financial advice
I’d watch Hershey for potential entry on dips given its stable dividends and growth, but avoid rushing as cocoa prices and health trends create uncertainty.
- USD/ZAR
- HSY
- Rising cocoa prices squeezing margins
- Impact of GLP-1 medicines on confectionery sales
6/10
The Milton Hershey School Trust sold 30,000 shares of Hershey Company stock for approximately $5.2 million on July 13-14, 2026, at weighted-average prices ranging from $169.44 to $177.64 per share. The trust retains substantial ownership with ~1.3 million common shares and ~54.6 million Class B shares. The transaction is characterized as routine portfolio management and should not concern investors. Hershey faces headwinds from cocoa prices and GLP-1 medicines but trades at a reasonable 20x forward earnings with a 3.4% dividend yield.
This article was originally published by The Motley Fool and has been adapted here for Axe Capital Trading News.
Publisher: The Motley Fool
Author: Josh Kohn-Lindquist
Categories: Macro, Inflation, Rates, Equities, Earnings, Capital Returns, Consumer, Retail
Tickers: HSY
Sentiment: Neutral - The insider sale is characterized as routine and non-concerning. While the company faces near-term headwinds from cocoa inflation and health trends, it shows stabilizing fundamentals with 11% recent sales growth, a reasonable valuation at 20x forward earnings, and a growing 3.4% dividend yield. The stock has underperformed historically but may rebound as it expands into higher-growth segments.
Keywords: insider selling, Hershey Company, Milton Hershey School Trust, share sale, dividend stock, consumer defensive, cocoa prices, GLP-1 medicines
Insights:
- HSY: Neutral: The insider sale is characterized as routine and non-concerning. While the company faces near-term headwinds from cocoa inflation and health trends, it shows stabilizing fundamentals with 11% recent sales growth, a reasonable valuation at 20x forward earnings, and a growing 3.4% dividend yield. The stock has underperformed historically but may rebound as it expands into higher-growth segments.